Michael-Bryant Hicks
CIK 1596081 · See Remarks · last filed 2022-03-29
Michael-Bryant Hicks is a corporate insider who has filed 21 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing, for APR, was dated Mar 29, 2022. Across all open-market trades the lifetime net is +$534.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $920.3K across reported positions. 8 SEC filings were submitted jointly with Elanco Animal Health Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ELAN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
TUCSON, AZ 85701
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apria, Inc. (APR) Delisted | See Remarks | — | $37.50 | — | $0 | 1 | 2022-03-29 |
| Elanco Animal Health Inc (ELAT) Delisted | See Remarks | 56,468 | $21.32 | $1.20M | $0 | 3 | 2021-03-03 |
| ELAN | See Remarks | 33,936 | $27.12 | $920.3K | $413.9K | 4 | 2019-08-26 |
| Keenova Therapeutics plc (MNK) Delisted | General Counsel | 16,342 | $0.34 | $5.6K | $178.9K | 6 | 2018-01-05 |
| ModivCare Inc (PRSC) Delisted | SVP, General Counsel & Sec | 2,246 | — | — | -$58.6K | 6 | 2016-02-26 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-29 | Apria, Inc. (APR) Delisted | Mixed | — | $0 | EDGAR |
| 2021-06-14 | — | Grant (A) | — | $0 | |
| 2021-03-03 | Elanco Animal Health Inc (ELAT) Delisted | Tax (F) | −1,679 | -$55.3K | EDGAR |
| 2021-02-24 | Elanco Animal Health Inc (ELAT) Delisted | Mixed | +15,130 | -$199.8K | EDGAR |
| 2020-03-03 | Elanco Animal Health Inc (ELAT) Delisted | Mixed | +8,201 | -$21.9K | EDGAR |
| 2019-08-26 | ELAN | Buy (P) | +11,030 | $293.9K | EDGAR |
| 2019-03-05 | ELAN | Grant (A) | +8,181 | $0 | EDGAR |
| 2018-10-23 | ELAN | Grant (A) | +9,725 | $0 | EDGAR |
| 2018-09-26 | ELAN | Buy (P) | +5,000 | $120.0K | EDGAR |
| 2018-01-05 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −467 | -$11.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.